Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancerfor Ovarian CancerSites in Milwaukee, Madison +19 more locationsSponsor: Regeneron PharmaceuticalsSex: Female·Age: 18+Code: NCT06787612·Phase 2·Recruiting·Listed Jan 2025Apply to this trial
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosisfor Multiple Sclerosis (MS) Primary ProgressiveSites in Milwaukee +17 more locationsSponsor: Zenas BioPharma (USA), LLCSex: All·Age: 18 - 60Code: NCT07067463·Phase 3·Recruiting·Listed Jul 2025Apply to this trial
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)for Treatment Resistant DepressionSites in Milwaukee +24 more locationsSponsor: Abbott Medical DevicesSex: All·Age: 22 - 70Code: NCT06423430·Recruiting·Listed May 2024Apply to this trial
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)for Carcinoma, Non-Small-Cell LungDrug: NavlimetostatSites in Milwaukee +8 more locationsSponsor: Bristol-Myers SquibbSex: All·Age: 18+Code: NCT06855771·Phase 2·Recruiting·Listed Mar 2025Apply to this trial
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissectionsfor Aortic DissectionSites in Milwaukee +21 more locationsSponsor: W.L.Gore & AssociatesSex: All·Age: 18+Code: NCT06827990·Recruiting·Listed Feb 2025Apply to this trial
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myelomafor Relapsed/Refractory Multiple MyelomaDrug: DaratumumabSites in Milwaukee, Madison +13 more locationsSponsor: BeOne MedicinesSex: All·Age: 18+Code: NCT04973605·Phase 1, Phase 2·Recruiting·Listed Jul 2021Apply to this trial
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignanciesfor B-cell MalignancySites in Milwaukee, Madison +15 more locationsSponsor: BeOne MedicinesSex: All·Age: 18+Code: NCT06634589·Phase 1, Phase 2·Recruiting·Listed Oct 2024Apply to this trial
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosisfor Multiple Sclerosis, Relapsing-RemittingSites in Milwaukee +8 more locationsSponsor: Bristol-Myers SquibbSex: All·Age: 10 - 17Code: NCT06408259·Phase 3·Recruiting·Listed May 2024Apply to this trial
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)for Non-Hodgkin LymphomaSites in Milwaukee +9 more locationsSponsor: Imugene LimitedSex: All·Age: 18+Code: NCT03666000·Phase 1·Recruiting·Listed Sep 2018Apply to this trial
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSAfor Aortic Arch AneurysmSites in Milwaukee +20 more locationsSponsor: Artivion Inc.Sex: All·Age: 18 - 80Code: NCT07089576·Recruiting·Listed Jul 2025Apply to this trial
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemiafor MyelofibrosisSites in Milwaukee +25 more locationsSponsor: Disc Medicine, IncSex: All·Age: 18+Code: NCT05320198·Phase 1, Phase 2·Recruiting·Listed Apr 2022Apply to this trial
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasmsfor Myeloproliferative NeoplasmsSites in Milwaukee +11 more locationsSponsor: Incyte CorporationSex: All·Age: 18+Code: NCT07008118·Phase 1·Recruiting·Listed Jun 2025Apply to this trial
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.for Lung Cancer (Diagnosis)Sites in Milwaukee +10 more locationsSponsor: bioAffinity Technologies Inc.Sex: All·Age: 50 - 80Code: NCT07168993·Recruiting·Listed Sep 2025Apply to this trial
A Long-term Follow-up Study in Patients Who Received BEAM-101for HemoglobinopathySites in Milwaukee +16 more locationsSponsor: Beam Therapeutics Inc.Sex: All·Age: 14 - 37Code: NCT07373639·Recruiting·Listed Jan 2026Apply to this trial
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancerfor Metastatic Castration-resistant Prostate CancerSites in Milwaukee +22 more locationsSponsor: Syncromune, Inc.Sex: Male·Age: 18+Code: NCT06533644·Phase 2·Recruiting·Listed Aug 2024Apply to this trial
XTX301 in Patients With Advanced Solid Tumorsfor Advanced Solid TumorSites in Milwaukee +9 more locationsSponsor: Xilio Development, Inc.Sex: All·Age: 18+Code: NCT05684965·Phase 1, Phase 2·Recruiting·Listed Jan 2023Apply to this trial
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignanciesfor Chronic Lymphocytic Leukemia (CLL)Sites in Milwaukee +14 more locationsSponsor: Nurix Therapeutics, Inc.Sex: All·Age: 18+Code: NCT05131022·Phase 1·Recruiting·Listed Nov 2021Apply to this trial
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPDfor COPDSites in Milwaukee +9 more locationsSponsor: Nuvaira, Inc.Sex: All·Age: 40 - 80Code: NCT07051707·Recruiting·Listed Jul 2025Apply to this trial
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancerfor Metastatic Castration-resistant Prostate CancerSites in Milwaukee +12 more locationsSponsor: Regeneron PharmaceuticalsSex: Male·Age: 18+Code: NCT05125016·Phase 1, Phase 2·Recruiting·Listed Nov 2021Apply to this trial
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)for Phenylketonuria (PKU)Drug: PalynziqSites in Milwaukee +11 more locationsSponsor: BioMarin PharmaceuticalSex: All·Age: All agesCode: NCT05813678·Recruiting·Listed Apr 2023Apply to this trial
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3for COPDSites in Milwaukee +17 more locationsSponsor: Apreo Health, Inc.Sex: All·Age: 40 - 84Code: NCT06891755·Recruiting·Listed Mar 2025Apply to this trial
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinibfor Chronic Lymphocytic LeukemiaSites in Milwaukee +19 more locationsSponsor: Eli Lilly and CompanySex: All·Age: 18+Code: NCT06876649·Phase 4·Recruiting·Listed Mar 2025Apply to this trial
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphomafor Chronic Lymphocytic LeukemiaSites in Milwaukee +15 more locationsSponsor: Eli Lilly and CompanySex: All·Age: 18+Code: NCT06876662·Phase 4·Recruiting·Listed Mar 2025Apply to this trial
Study of SGR-1505 in Mature B-Cell Neoplasmsfor Mature B-Cell NeoplasmSites in Milwaukee +15 more locationsSponsor: Schrödinger, Inc.Sex: All·Age: 18+Code: NCT05544019·Phase 1·Recruiting·Listed Sep 2022Apply to this trial
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)for Epilepsy, Temporal LobeSites in Milwaukee +15 more locationsSponsor: Neurona TherapeuticsSex: All·Age: 18 - 75Code: NCT06422923·Phase 1, Phase 2·Recruiting·Listed May 2024Apply to this trial
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancerfor Breast CancerDrug: RibociclibSites in Milwaukee +9 more locationsSponsor: Hoffmann-La RocheSex: All·Age: 18+Code: NCT07405801·Phase 2·Recruiting·Listed Feb 2026Apply to this trial
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemiafor Chronic Lymphocytic LeukemiaDrug: SonrotoclaxSites in Milwaukee +20 more locationsSponsor: BeOne MedicinesSex: All·Age: 18+Code: NCT07277231·Phase 3·Recruiting·Listed Dec 2025Apply to this trial
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumorsfor Advanced Solid TumorSites in Milwaukee +6 more locationsSponsor: BeOne MedicinesSex: All·Age: 18+Code: NCT07226349·Phase 1·Recruiting·Listed Nov 2025Apply to this trial
A Study of BGB-11417 in Participants With Myeloid Malignanciesfor Acute Myeloid LeukemiaSites in Milwaukee +3 more locationsSponsor: BeOne MedicinesSex: All·Age: 18+Code: NCT04771130·Phase 1, Phase 2·Recruiting·Listed Feb 2021Apply to this trial
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)for Small Cell Lung CancerDrug: GocatamigSites in Milwaukee +8 more locationsSponsor: Merck Sharp & Dohme LLCSex: All·Age: 18+Code: NCT06780137·Phase 1, Phase 2·Recruiting·Listed Jan 2025Apply to this trial
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Studyfor Relapsing Remitting Multiple SclerosisSites in Milwaukee +8 more locationsSponsor: SetPoint Medical CorporationSex: All·Age: 22 - 60Code: NCT06796504·Recruiting·Listed Jan 2025Apply to this trial
A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutationsfor Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)Sites in Milwaukee +8 more locationsSponsor: Regeneron PharmaceuticalsSex: All·Age: All agesCode: NCT05788536·Phase 1, Phase 2·Recruiting·Listed Mar 2023Apply to this trial
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)for Metastatic Castration-resistant Prostate CancerSites in Milwaukee +8 more locationsSponsor: Daiichi SankyoSex: Male·Age: 18+Code: NCT07244341·Phase 1·Recruiting·Listed Nov 2025Apply to this trial
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancerfor Prostate CancerSites in Milwaukee +6 more locationsSponsor: AmgenSex: Male·Age: 18+Code: NCT06613100·Phase 1·Recruiting·Listed Sep 2024Apply to this trial
Asciminib Roll-over Studyfor Chronic Myelogenous LeukemiaSites in Milwaukee +4 more locationsSponsor: Novartis PharmaceuticalsSex: All·Age: 7 - 100Code: NCT04877522·Phase 4·Recruiting·Listed May 2021Apply to this trial
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignanciesfor Acute Myelogenous LeukemiaSites in Milwaukee +5 more locationsSponsor: Beijing InnoCare Pharma Tech Co., Ltd.Sex: All·Age: 18+Code: NCT06656494·Phase 1·Recruiting·Listed Oct 2024Apply to this trial
REMASTer: REcurrent Brain Metastases After SRS Trialfor Brain MetastasesSites in Milwaukee +7 more locationsSponsor: Monteris MedicalSex: All·Age: 18+Code: NCT05124912·Recruiting·Listed Nov 2021Apply to this trial
Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders.for ArthritisSites in Milwaukee +5 more locationsSponsor: Aptis MedicalSex: All·Age: 18 - 85·Accepts healthy volunteersCode: NCT05796908·Recruiting·Listed Apr 2023Apply to this trial
SPI-1005 in Adults Receiving Cochlear Implantfor Hearing LossSites in Milwaukee +5 more locationsSponsor: Sound Pharmaceuticals, IncorporatedSex: All·Age: 18+Code: NCT06340633·Phase 2·Recruiting·Listed Apr 2024Apply to this trial
Combination of TATE and PD-1 Inhibitor in Liver Cancerfor Hepatocellular CarcinomaSites in Milwaukee +2 more locationsSponsor: Teclison Ltd.Sex: All·Age: 18 - 80Code: NCT03259867·Phase 2·Recruiting·Listed Aug 2017Apply to this trial